BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 3.44 EUR -0.86% Market Closed
Market Cap: 75.2m EUR
Have any thoughts about
BRAIN Biotech AG?
Write Note

Balance Sheet

Balance Sheet Decomposition
BRAIN Biotech AG

Current Assets 29.3m
Cash & Short-Term Investments 10.4m
Receivables 8.8m
Other Current Assets 10.1m
Non-Current Assets 43.9m
Long-Term Investments 1.1m
PP&E 28.2m
Intangibles 14.6m
Other Non-Current Assets 78k
Current Liabilities 14.6m
Accounts Payable 4.5m
Other Current Liabilities 10.1m
Non-Current Liabilities 40.3m
Long-Term Debt 4.3m
Other Non-Current Liabilities 36m

Balance Sheet
BRAIN Biotech AG

Rotate your device to view
Balance Sheet
Currency: EUR
Sep-2014 Sep-2015 Sep-2016 Sep-2017 Sep-2018 Sep-2019 Sep-2020 Sep-2021 Sep-2022 Sep-2023
Assets
Cash & Cash Equivalents
4
3
8
39
26
15
19
25
8
5
Cash Equivalents
4
3
8
39
26
15
19
25
8
5
Short-Term Investments
0
0
10
0
0
0
0
0
0
0
Total Receivables
3
4
6
7
7
7
7
7
11
10
Accounts Receivables
2
3
3
4
5
6
6
6
7
9
Other Receivables
0
1
3
3
1
1
1
0
4
1
Inventory
5
7
7
7
8
8
7
7
10
10
Other Current Assets
0
1
0
0
1
1
1
0
1
0
Total Current Assets
12
15
32
54
41
31
33
39
30
25
PP&E Net
7
7
7
8
12
17
24
24
29
29
PP&E Gross
0
7
7
8
12
17
24
24
29
29
Accumulated Depreciation
0
6
6
7
8
9
10
13
14
17
Intangible Assets
6
5
5
4
13
11
9
9
10
9
Goodwill
0
3
3
3
6
5
4
5
7
7
Note Receivable
0
0
0
0
0
1
0
0
0
0
Long-Term Investments
0
0
0
0
2
1
1
1
2
1
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
Other Assets
0
3
3
3
6
5
4
5
7
7
Total Assets
25
N/A
30
+20%
48
+56%
69
+44%
74
+9%
66
-11%
72
+9%
78
+8%
78
+0%
71
-9%
Liabilities
Accounts Payable
1
3
3
2
3
4
3
4
7
6
Accrued Liabilities
0
0
0
0
0
1
3
2
2
3
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
2
2
3
2
2
2
2
2
3
4
Other Current Liabilities
2
3
4
4
6
7
4
3
10
5
Total Current Liabilities
5
8
10
8
11
15
12
11
21
17
Long-Term Debt
7
14
6
8
25
5
11
9
8
18
Deferred Income Tax
1
1
1
1
3
3
2
3
3
4
Minority Interest
0
0
0
0
5
5
5
3
5
1
Other Liabilities
0
1
3
3
7
23
21
13
11
9
Total Liabilities
13
N/A
25
+88%
21
-17%
21
+2%
51
+139%
51
0%
51
+1%
39
-24%
48
+24%
49
+2%
Equity
Common Stock
13
13
16
18
18
18
20
22
22
22
Retained Earnings
1
7
10
29
5
68
77
80
85
94
Additional Paid In Capital
0
0
0
0
0
65
78
96
93
93
Other Equity
0
0
0
0
0
0
0
1
0
1
Total Equity
12
N/A
5
-55%
27
+389%
47
+77%
24
-50%
15
-35%
21
+36%
39
+87%
30
-24%
22
-27%
Total Liabilities & Equity
25
N/A
30
+20%
48
+56%
69
+44%
74
+9%
66
-11%
72
+9%
78
+8%
78
+0%
71
-9%
Shares Outstanding
Common Shares Outstanding
13
13
16
18
18
18
20
22
22
22

See Also

Discover More